- Antitumor Effects of Evodiamine in Mice Model Experiments: A Systematic Review and Meta-Analysis
Cong Yin et al, 2021, Frontiers in Oncology CrossRef - Research progress on evodiamine, a bioactive alkaloid of Evodiae fructus: Focus on its anti‑cancer activity and bioavailability (Review)
Chaodan Luo et al, 2021, Experimental and Therapeutic Medicine CrossRef - Prioritization of bioactive compounds envisaging yohimbine as a multi targeted anticancer agent: insight from molecular docking and molecular dynamics simulation
Nasimudeen R. Jabir et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef - Evodiamine inhibits proliferation and induces apoptosis of nasopharyngeal carcinoma cells via the SRC/ERBB2-mediated MAPK/ERK signaling pathway
Jie Liu et al, 2024, Journal of Translational Medicine CrossRef - Research Advances in Antitumor Mechanism of Evodiamine
Luning Li et al, 2022, Journal of Chemistry CrossRef - Evodiamine as the Active Compound of Evodiae fructus to Inhibit Proliferation and Migration of Prostate Cancer through PI3K/AKT/NF-κB Signaling Pathway
Yuhe Lei et al, 2022, Disease Markers CrossRef - The Design, Synthesis, and Evaluation of Evodiamine Derivatives with Hydroxy Groups
Zheng Yang et al, 2023, Letters in Drug Design & Discovery CrossRef - Exploiting Nanotechnology for Drug Delivery: Advancing the Anti-Cancer Effects of Autophagy-Modulating Compounds in Traditional Chinese Medicine
Zixian Liu et al, 2024, International Journal of Nanomedicine CrossRef - Evodiamine: A Extremely Potential Drug Development Candidate of Alkaloids from Evodia rutaecarpa
Longfei Lin et al, 2024, International Journal of Nanomedicine CrossRef - Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer
Shengtao Xu et al, 2021, Journal of Medicinal Chemistry CrossRef - PI3K and tankyrase inhibitors as therapeutic targets in colorectal cancer
Prasanna Anjaneyulu Yakkala et al, 2024, Expert Opinion on Therapeutic Targets CrossRef - Effect of Evodiamine on Collagen-Induced Platelet Activation and Thrombosis
Xiaona Yang et al, 2022, BioMed Research International CrossRef - Evo312: An Evodiamine Analog and Novel PKCβI Inhibitor with Potent Antitumor Activity in Gemcitabine-Resistant Pancreatic Cancer
Eun Seo Bae et al, 2024, Journal of Medicinal Chemistry CrossRef - Research Advancement of Natural Active Components in Alleviating Lung Damage Induced by PM2.5
Zhaohui Xue et al, 2023, Food Reviews International CrossRef